Glucosamine and chondroitine sulphate as a possible treatment for osteoarthritis;Glucosamine en chondroïtinezwavelzuur als mogelijke behandeling van artrose

Nederlands Tijdschrift voor Geneeskunde

Volumn 146, Issue 39, 2002, Pages 1819-1823

  Bijlsma, J W J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; GLUCOSAMINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; DIET SUPPLEMENTATION; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; DRUG INDUCED DISEASE; HUMAN; NUTRITION; OSTEOARTHRITIS; PAIN; RADIOGRAPHY; TREATMENT PLANNING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHONDROITIN SULFATES; DIETARY SUPPLEMENTS; GLUCOSAMINE; HUMANS; OSTEOARTHRITIS; TREATMENT OUTCOME;

EID: 0037190447     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bijlsma JWJ, Romijnders ACM. Artrose. In: Bijlsma JWJ, Voorn ThB, redacteuren. Praktische huisartsgeneeskunde, reumatologie. Houten: Bohn Stafleu Van Loghum; 2000. p. 194-205.
2. McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 2000;283:1469-75.
3. Reichelt A, Forster KK, Fischer M, Rovati LC, Setnikar I. Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee. A randomised, placebo-controlled, double-blind study. Arzneimittelforschung 1994;44:75-80.
4. Vajaradul Y. Double-blind clinical evaluation of intra-articular glucosamine in outpatients with gonarthrosis. Clin Ther 1981;3: 336-43.
5. Pujalte JM, Llavore EP, Ylescupidez FR. Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthrosis. Curr Med Res Opin 1980;7:110-4.
6. Noack W, Fischer M, Forster KK, Rovati LC, Setnikar I. Glucosamine sulfate in osteoarthritis of the knee. Osteoarthritis Cartilage 1994;2:51-9.
7. Rovati LC. The clinical profile of glucosamine sulphate as a selective symptom modifying drug in osteoarthritis: current data and perspectives [abstract]. Osteoarthritis Cartilage 1997;5 Suppl A:72.
8. Houpt JB, McMillan R, Paget-Dellio SD, Russell A, Gahunia HK. Effect of glucosamine hydrochloride (GHcl) in the treatment of pain of osteoarthritis of the knee [abstract]. J Rheumatol 1998;25 Suppl 52:8.
9. Lopes Vaz A. Double-blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine sulphate in the management of osteoarthrosis of the knee in out-patients. Curr Med Res Opin 1982;8:145-9.
10. Muller-Fassbender H, Bach GL, Haase W, Rovati LC, Setnikar I. Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee. Osteoarthritis Cartilage 1994;2:61-9.
11. Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyere O, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 2001;357:251-6.
12. Hauselmann HJ. Nutripharmaceuticals for osteoarthritis. Baillieres Best Pract Res Clin Rheumatol 2001;15:595-607.
13. Bourgeois P, Chales G, Dehais J, Delcambre B, Kuntz JL, Rozenberg S. Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 × 400 mg/day vs placebo. Osteoarthritis Cartilage 1998;6 Suppl A:25-30.
14. Bucsi L, Poor G. Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis. Osteoarthritis Cartilage 1998;6 Suppl A:31-6.
15. Uebelhart D, Thonar EJ, Delmas PD, Chantraine A, Vignon E. Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study. Osteoarthritis Cartilage 1998;6 Suppl A:39-46.
16. Pavelka K, Bucsi L, Manopulo R. Double-blind, dose effect study of oral CS 4&6 1200 mg, 800 mg, 200 mg against placebo in the treatment of femoro-tibial osteoarthritis. Eular Rheumatol Litera 1998;27 Suppl 2:63.
17. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
18. Kerzberg EM, Roldan EJ, Castelli G, Huberman ED. Combination of glycosaminoglycans and acetylsalicylic acid in knee osteoarthrosis. Scand J Rheumatol 1987;16:377-80.
19. Mazieres B, Loyau G, Menkes CJ, Valat JP, Dreiser RL, Charlot J, et al. Le chondroitine sulfate dans le traitement de la gonarthrose et de la coxarthrose. Résultats à 5 mois, d'une étude prospective multicentrique, controlée, en double aveugle, versus placebo. Rev Rhum Mal Osteoartic 1992;59:466-72.
20. Mazieres B, Combe B, Phan Van A, Tondut J, Grynfeltt M. Chondroitin sulfate in osteoarthritis of the knee: a prospective, double blind, placebo controlled multicenter clinical study. J Rheumatol 2001;28:173-81.
21. Rovetta G. Galactosaminoglycuronoglycan sulfate (matrix) in therapy of tibiofibular osteoarthritis of the knee. Drugs Exp Clin Res 1991;17:53-7.
22. Conrozier T. Les traitements anti-arthrosiques: efficacité et tolérance des chondroitines sulfates (CS 4&6). Presse Med 1998;27:1862-5.
23. Morreale P, Manopulo R, Galati M, Boccanera L, Saponati G, Bocchi L, et al. Comparison of the antiinflammatory efficacy of chondroitin sulphate and diclofenac sodium in patients with knee osteoarthritis. J Rheumatol 1999;26:1385-91.
24. Chalmers TC, Smith jr H, Blackburn B, Silverman B, Schroeder B, Reitman D, et al. A method for assessing the quality of a randomized control trial. Control Clin Trials 1981;2:31-49.
25. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, N.J.: Lawrence Erlbaum; 1988.